Cleopatra Hospital Company · EGX:CLHO
Cleopatra Hospital — 9M 2025 Earnings Presentation
69 slides from Cleopatra Hospital's earnings presentation, 2025
Slide 1: Transforming Healthcare in Egypt
Transforming Healthcare in Egypt Investor Presentation 9M 2025
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements, including, but not limited to, statements concerning expectations, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating
Slide 3: Contents
CONTENTS 1 Cleopatra Hospitals Group Highlights 2 Macro Environment 3 Competitive Advantages 4 Growth Strategy & New Business 5 Governance & Management Information 6 9M 2025 in Review 7 Appendix
Slide 4: Cleopatra Hospitals Group Highlights
Cleopatra Hospitals Group Highlights 4
Slide 5: Our Mission, Vision and Values
Our Mission, Vision and Values ➢ A Patient-First Approach to Healthcare Our Mission • Delivering Leading Quality Services • Ensuring Safety of all Stakeholders • Growing Beds Supply & Expanding their Distribution • Improving Quality of Lives Everyday ➢ Sustainable Growth & Cross-Asset Collaboration
Slide 6: Cleopatra Hospitals Group Reports 9M 2025 Results
Cleopatra Hospitals Group Reports 9M 2025 Results CHG maintained its steep 9M 2025 Snapshot consolidated top-line’s growth trajectory and delivered record- breaking quarterly and nine- month performances in 9M 2025. The Group’s consolidated EGP 5,320 mn EGP 2,084 mn Consolidated revenues in 9M 2025
Slide 7: CHG enjoys a Broad Network spread Across Greater Cairo
CHG enjoys a Broad Network spread Across Greater Cairo, penetrating underserved regions Leveraging a growing footprint, CHG continues to penetrate new segments of the population and provide high quality care to underserved regions across Greater Cairo Leveraging a growing footprint, CHG continues to
Slide 8: The Group is a Fast Growing, Diversified Healthcare Services Provider
The Group is a Fast Growing, Diversified Healthcare Services Provider Group Revenue, EBITDA and Margins | EGP mn Revenue CAGR: 25% 5,420 5,320 3,595 31.9% 28.2% 3,832 2,549 2,614 27.1% 28.9% 29.9% 26.5% 1,529 1,699 2,532 26.8% 1,798 27.9% 1,990 27.1% 1,108 763 709 954 502 540 678 2019 2020 2021 20
Slide 9: Macro Environment
Macro Environment 9
Slide 10: Growing Population & Prevalence of Lifestyle Diseases
Growing Population & Prevalence of Lifestyle Diseases Demographics Common Illnesses Breast Cancer Cases Communicable Diseases Lung Cancer Cases CAGR 3% 382,642 Cases CAGR 3% Acute Respiratory illness 33,863 Cases Chicken Pox 7,521 Cases 23,081 40,544 11,945 Brucella 6,045 2018 2040 2018 2040 • The m
Slide 11: Egypt's Healthcare Market Structure
Egypt’s Healthcare Market Structure Hospitals by Governorate and Geographical Disparities Medical Services in the Region EGYPT GCC MENA • Healthcare facilities are highly • Doctor/1,000 population ratio for concentrated in Cairo, Alexandria, Egypt is higher than both MENA Daqahleya & Giza which toge
Slide 12: Healthcare Investments in Egypt
Healthcare Investments in Egypt Private Sector as a % of total Healthcare Expenditure (2023) Government Spending 62% Government Healthcare Expenditure % of Total Expenditure 56% 58% 6.8% 4.7% 4.8% 5.2% 40% 39% 34% 36% 23% 21% 2018 2019 2020 2021 15% • Egypt’s House of Representatives approved budget
Slide 13: Competitive Advantages
P 7, -e . ae >» _ Benpstve 4 lam end = vantages
Slide 14: A leading healthcare services platform with sustainable competitive advantages
A leading healthcare services platform with sustainable competitive advantages CHG was a pioneering force in Egypt's private healthcare sector, recognizing its potential early on. The Group introduced an innovative 360-degree integrated management system, focused on delivering quality patient care a
Slide 15: Key Pillars That Make Up CHG's Definition of Centers of Excellence
A High-Level Perspective on the Key Pillars That Make Up CHG’s Definition of Centers of Excellence Defining Centers of Excellence Select Examples of CHG’s Centers of Excellence Competitive Defined Scope & Nursing & Residents Advantage & Sales Focus Team Differentiation Consumables Medical Equipment
Slide 16: Growth Strategy & New Business
Growth Strategy & New Business 16
Slide 17: Defined Core Growth Strategy
Defined Core Growth Strategy Integrating the platform to Leveraging payor and achieve higher efficiencies supplier relationships Geographic expansion in Egypt Enhancing utilization and linked to following optimizing existing capacity Establish centers of while expanding capacities and the main payor
Slide 18: Cleopatra October Hospital – CHG's Flagship Hospital of West Cairo
Cleopatra October Hospital – CHG’s Flagship Hospital of West Cairo & the Latest Addition Facility Overview Cleopatra October Current Facility + Extension Building • Transformed by CHG into a world-class tertiary hospital specialized in orthopedics, spine, rehabilitation & sports injuries (largest CO
Slide 19: Network expansion through Cleopatra El Tagamoa Hospital
CHG continues its network expansion into underserved regions through Cleopatra El Tagamoa Hospital – East Cairo’s new State-of-the-Art Flagship project • In line with CHG’s strategy to expand into underserved regions, the Group is launching a top-tier hospital in East Cairo that will introduce c.240
Slide 20: Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks
Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks 2 Main Entrances 20
Slide 21: Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks
Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks Reception Atrium 21
Slide 22: Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks
Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks CHG Academy and Auditorium 22
Slide 23: Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks
Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks Emergency Room Outpatient Clinics Pharmacy OPD 23
Slide 24: Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks
Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks Operating Room Inpatient Room 24
Slide 25: Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks
Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks Pharmacy Dialysis 25
Slide 26: Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks
Cleopatra El Tagamoa Hospital Prepares for Launch in the Coming Weeks Dentistry CCU 26
Slide 27: Governance & Management Information
Governance & Management Information 27
Slide 28: CHG employs best-in-class corporate governance standards
CHG employs best-in-class corporate governance standards that are in line with the highest international standards… OPERATIONS ABC No Referral Fees Medical Council • CHG has a zero-tolerance approach to bribery and • CHG does not pay any referral fees or kickbacks to • CHG recently launched a group-
Slide 29: Board of directors dominated by experienced independent and non-executive directors
… supported by a board of directors dominated by experienced independent and non-executive directors and focused on growing shareholder value… The Group’s Board of Directors provide the necessary oversight and combination of expertise to thoroughly oversee the Group’s corporate governance framework,
Slide 30: Highly competent and ambitious management team
… and led by a highly competent and ambitious management team comprised of accomplished industry veterans with vast experience in the healthcare sector The Group is managed by a seasoned team that brings along deep industry experience to their respective positions gained in leading regional and mult
Slide 31: 9M 2025 in Review
9M 2025 in Review 31
Slide 32: Our Strategy drives consistent long-term value
Our Strategy drives consistent long-term value Cases Outpatient Inpatients Surgeries Revenues Served Visits 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 10.7% 10.3% 14.0% 8.1% 28.6% 9M 2025: 9M 2025: 9M 2025: 9M 2025: 9M 2025: 1,078,720 55,706 883,112 32,599 EGP 5,320mn Y-o-Y Gro
Slide 33: 9M 2025 Financial Performance Overview
9M 2025 Financial Performance Overview 9M 2025 Snapshot ▪ CHG maintained its steep consolidated top-line’s growth trajectory and delivered record-breaking nine-month performances in 9M 2025. The Group’s 9M 2025 consolidated revenues marked an all-time high at EGP 5,320mn, exhibiting an impressive 39
Slide 34: Efficiency Strategies Lead to Optimized Profitability
Efficiency Strategies Lead to Optimized Profitability ▪ The strength of management’s multi-pronged efficiency strategy was evident in Consulting Key COGS Cost Components to Revenue Ratios Physicians fees and Staff Costs, which each declined by 1% in 9M2025, reaching 13% and 14% of revenues, respecti
Slide 35: Group Revenue Contribution by Hospital
Group Revenue Contribution by Hospital Revenue Contribution by Hospital – 9M24 1% Cleopatra Hospital (CHC) 3% ▪ Largest revenue contributor in 9M2025 (32% of Group revenues, EGP 1,739mn, +32% y-o-y) 4% 2% ▪ Consistent growth in cases served in 9M2025 (+6% y-o-y) 5% ▪ Broad-based volume increases acr
Slide 36: Group Revenue Contribution by Segment
Group Revenue Contribution by Segment Revenue Contribution by Segment – 9M24 Inpatient Services 13% ▪ Contributed 23% of revenues in 9M2025 & 22% in 3Q2025 20% ▪ Revenues +45% y-o-y in 9M2025 (+35% in 3Q2025) 3% 6% ▪ Driven by +14% volumes (9M) / +14% volumes (3Q) ▪ ARP growth +27% (9M) / +18% (3Q)
Slide 37: Core Business Driven Growth
Core Business Driven Growth Volume, ARP, & Revenue | Volume, ARP, & Revenue | Volume, ARP, & Revenue | Surgeries Outpatients Laboratory EGP 24,477 Rev. in EGP Mn. Vol. In 000’ Rev. in EGP Mn. Vol. In 000’ Rev. in EGP Mn. EGP 29,402 35,0 00 1,20 0 1,00 0 EGP 454 EGP 518 500 1,80 0 EGP 239 EGP 314 700
Slide 38: Balance Sheet Highlights
Balance Sheet Highlights CAPEX Profile and Cash Flow Highlights ▪ The Group maintained its focus on network expansion and upgrades, with CAPEX outlays reaching c. EGP 1.98bn in 9M 2025. ▪ Around 96% of spending related to assets for projects currently under construction. ▪ The largest share was allo
Slide 39: CLHO.CA Share Performance
CLHO.CA Share Performance CHG’s Price Performance | Rebased to 100 Valuation Multiples 1 Month VWAP Closing Nov 30th 14 11.59 11.70 12.4x 10.8x 8.9x 8.0x 12 7.6x 7.7x EV/EBITDA Valuation 10 Multiples (x) Volume (mn) 8 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 Q3 2025 6 4 29.8x 23.8x P/E 17.7x 2 14.0x
Slide 40: Appendix: Financial Statements
Appendix: Financial Statements 41
Slide 41: Consolidated Income Statement
Consolidated Income Statement Income Statement | EGP mn 3Q2024 3Q2025 % Change 9M2024 9M2025 % Change Revenues 1,459.7 1,938.1 32.8% 3,832.1 5,320.2 38.8% Cost of sales (915.5) (1,163.3) 27.1% (2,424.1) (3,236.0) 33.5% Gross profit 544.2 774.8 42.4% 1,408.1 2,084.2 48.0% Gross Profit Margin 37.3% 40
Slide 42: Consolidated Balance Sheet
Consolidated Balance Sheet Balance Sheet | EGP mn a 31 December 2024 30 September 2025 Non-current assets Fixed assets 4,642.2 6,460.9 Intangible assets 405.2 403.7 Right of use 75.6 136.6 Revenue Share Down Payment - 284.8 Investment in associates 8.5 8.5 Total non-current assets 5,131.6 7,294.5 Cu
Slide 43: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement | EGP 30 September 2024 30 September 2025 Cash flow from operating activities: Profit before tax 788.5 1,123.7 Adjustments for: Depreciation 133.9 162.7 Amortization of intangible assets 1.6 1.6 Allowance for impairment of current assets 36.1 71.2
Slide 44: Appendix: Photo Library
Appendix: Photo Library 45
Slide 45: Cleopatra Hospital
CHG Cleopatra Hospital 46
Slide 46: Cairo Specialized Hospital
Cairo Specialized Hospital 47
Slide 47: Nile Badrawi Hospital
®| Nile Badrawi Hospital 48
Slide 48: Al Shorouk Hospital
®| Al Shorouk Hospital 49 @ee
Slide 49: Cleopatra October Hospital
Cleopatra October Hospital 50
Slide 50: Cleopatra El Tagamoa Hospital
Cleopatra El Tagamoa Hospital 51
Slide 51: El Katib Hospital
®| El Katib Hospital a a. | A a 7
Slide 52: Bedaya Hospital
Bedaya Hospital 53
Slide 53: Cleopatra Clinics (East Cairo)
Cleopatra Clinics (East Cairo) 54
Slide 54: Cleopatra Clinics (West Cairo)
Cleopatra Clinics (West Cairo) 55
Slide 55: Cleopatra Clinics (Maadi)
Cleopatra Clinics (Maadi) 56
Slide 56: Cleopatra Clinics (Suez Governorate)
Cleopatra Clinics (Suez Governorate) 57
Slide 57: Cleopatra Clinics (Pyramids Clinic)
Cleopatra Clinics (Pyramids Clinic) 58
Slide 58: Cleo Alfa Cure – Oncology Center of Excellence
Cleo Alfa Cure – Oncology Center of Excellence 59
Slide 59: Cairo Specialized Hospital – Bone Marrow Transplantation Unit
Cairo Specialized Hospital – Bone Marrow Transplantation Unit 60
Slide 60: Cleopatra October Hospital – Aqua Therapy
Cleopatra October Hospital – Aqua Therapy 61
Slide 61: CleoDent – Dental Center of Excellence
CleoDent – Dental Center of Excellence 62
Slide 62: CleoSphinx – Nephrology Center of Excellence
CleoSphinx – Nephrology Center of Excellence 63
Slide 63: Nile Badrawi Hospital – Radiotherapy Center of Excellence
Nile Badrawi Hospital – Radiotherapy Center of Excellence 64
Slide 64: Al Shorouk Hospital – RoboSurgery Center of Excellence
Al Shorouk Hospital – RoboSurgery Center of Excellence 65
Slide 65: Al Shorouk Hospital – Newly Renovated Inpatient Ward
Al Shorouk Hospital – Newly Renovated Inpatient Ward 66
Slide 66: Cleopatra Hospital – Outpatient Clinics
Cleopatra Hospital – Outpatient Clinics 67
Slide 67: Cairo Specialized Hospital – Emergency Department
Cairo Specialized Hospital – Emergency Department 68
Slide 68: Al Shorouk Clinics
[@] Al Shorouk Clinics @e 69
Slide 69: Thank you
Thank you INVESTOR RELATIONS CONTACTS SHAREHOLDER INFORMATION ir@cleohc.com Email: ir@cleohc.com https://www.cleopatrahospitals.com/en/investors/ EGX: CLHO.CA Website: https://www.cleopatrahospitals.com/en/investors/ Listed: June 2016 Shares Outstanding: 1.4 billion 70
Cleopatra Hospital Company — 9M 2025 Earnings Presentation on 6ix